Literature DB >> 26895323

Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

A Loraschi1, P Bellantonio2, F Bortolon3, R Capra4, P Cavalla5, G Costantino6, A Lugaresi7, V Martinelli8, M G Marrosu9, F Patti10, M Rottoli11, M Salvetti12, P Sola13, C Solaro14, C Klersy15, F Marino1, M Zaffaroni16, M Cosentino17.   

Abstract

Though recent progress in multiple sclerosis (MS) treatment is remarkable, numerous unmet needs remain to be addressed often inducing patients to look for complementary and alternative medicines (CAM), especially herbal remedies (HR). HR use, scarcely investigated in MS, may cause adverse reactions (AR) and interfere with conventional treatment. We performed a survey aimed at evaluating use and attitudes towards HR and factor associated to HR use. Other CAM use and attitudes have been investigated as well. Multiple-choice questionnaires were distributed to MS out patients attending 14 Italian referral Centers. Multivariable logistic regression was used to identify HR use determinants. Present/past HR use for either MS or other diseases was reported in 35.6 % of 2419 cases (95 % CI 36.0-40.0 %). CAM use was reported in 42.5 % of cases. Independent predictors of HR use were represented by higher education, geographic area, dissatisfaction with conventional treatment of diseases other than MS and benefit perception from CAM use. Both HR and CAM use were not always disclosed to the healthcare professional. In conclusion, HR and other CAM appear to be popular among MS patients. The involvement of the healthcare professionals appears to be scarce with potential risk of AR or interference with conventional treatments.

Entities:  

Keywords:  Complementary alternative medicine; Herbal remedies; Multiple sclerosis; Nation-wide survey; Questionnaire; Unmet needs

Mesh:

Year:  2016        PMID: 26895323     DOI: 10.1007/s10072-016-2519-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Medicinal herb use in a population-based survey of adults: prevalence and frequency of use, reasons for use, and use among their children.

Authors:  Anne G Wheaton; Heidi Michels Blanck; Ziya Gizlice; Michele Reyes
Journal:  Ann Epidemiol       Date:  2005-10       Impact factor: 3.797

2.  Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?

Authors:  E M Leong; S J Semple; M Angley; W Siebert; J Petkov; R A McKinnon
Journal:  Complement Ther Med       Date:  2009-04-21       Impact factor: 2.446

3.  The future of multiple sclerosis therapy.

Authors:  Bernd C Kieseier; Heinz Wiendl; Hans-Peter Hartung; Olaf Stüve
Journal:  Pharmacol Res       Date:  2009-04-05       Impact factor: 7.658

Review 4.  Clinically based evidence of drug-herb interactions: a systematic review.

Authors:  Deborah A Kennedy; Dugald Seely
Journal:  Expert Opin Drug Saf       Date:  2010-01       Impact factor: 4.250

5.  Use of unconventional therapies by individuals with multiple sclerosis.

Authors:  Sangeetha Nayak; Robert J Matheis; Nancy E Schoenberger; Samuel C Shiflett
Journal:  Clin Rehabil       Date:  2003-03       Impact factor: 3.477

6.  Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.

Authors:  Lasse Skovgaard; Inge Kryger Pedersen; Marja Verhoef
Journal:  Int J MS Care       Date:  2014

7.  Complementary and alternative medicine use in veterans with multiple sclerosis: Prevalence and demographic associations.

Authors:  Duncan G Campbell; Aaron P Turner; Rhonda M Williams; Michael Hatzakis; James D Bowen; Arthur Rodriquez; Jodie K Haselkorn
Journal:  J Rehabil Res Dev       Date:  2006 Jan-Feb

8.  Patterns of dietary and herbal supplement use by multiple sclerosis patients.

Authors:  Kerri O'Connor; Bianca Weinstock-Guttman; Ellen Carl; Colleen Kilanowski; Robert Zivadinov; Murali Ramanathan
Journal:  J Neurol       Date:  2011-09-06       Impact factor: 4.849

Review 9.  Historical and clinical perspectives of the expanded disability status scale.

Authors:  John F Kurtzke
Journal:  Neuroepidemiology       Date:  2008-06-06       Impact factor: 3.282

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  6 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.

Authors:  Soohyun Kim; Lawrence Chang; Bianca Weinstock-Guttman; Sirin Gandhi; Dejan Jakimovski; Ellen Carl; Robert Zivadinov; Murali Ramanathan
Journal:  J Altern Complement Med       Date:  2018-03-02       Impact factor: 2.579

3.  "I need personal experiences or some sort of documentation": a qualitative study on where people with multiple sclerosis seek information on dietary and herbal supplements.

Authors:  Sofie Bergien; Clara M Petersen; Marie Lynning; Maria Kristiansen; Lasse Skovgaard
Journal:  BMC Complement Med Ther       Date:  2021-08-21

4.  Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review.

Authors:  Mayuree Tangkiatkumjai; Helen Boardman; Dawn-Marie Walker
Journal:  BMC Complement Med Ther       Date:  2020-11-23

5.  Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review.

Authors:  Alessia Furgiuele; Marco Cosentino; Marco Ferrari; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2021-01-25       Impact factor: 4.147

Review 6.  Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches.

Authors:  Maria Teresa Gentile; Gianluca Muto; Giacomo Lus; Karl-Olof Lövblad; Åsa Fex Svenningsen; Luca Colucci-D'Amato
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.